Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAUSCH AND LOMB INC

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 36
  • 0 comments

FDA approve BRIMONIDINE TARTRATE

Comment Full text

VIVUS INC

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 37
  • 0 comments

FDA approve PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Comment Full text

ABBVIE

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 34
  • 0 comments

FDA approve PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Comment Full text

NIVAGEN PHARMS INC

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 37
  • 0 comments

FDA approve SODIUM BICARBONATE

Comment Full text

AUROBINDO PHARMA LTD

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 35
  • 0 comments

FDA approve MESALAMINE

Comment Full text

MSN

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 31
  • 0 comments

FDA approve CLOBAZAM

Comment Full text

B BRAUN MEDICAL INC

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 33
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

SUN PHARM INDUSTRIES

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 32
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 36
  • 0 comments

FDA approve DAPAGLIFLOZIN

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Feb. 29, 2024, 10:05 UTC
  • 32
  • 0 comments

FDA approve COLESEVELAM HYDROCHLORIDE

Comment Full text
  • Previous
  • 538
  • 539
  • 540
  • 541
  • 542
  • Next

Search

News categories

  • Technical Exchange News(11766)
  • Event(4289)
  • SEC News(235879)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143296)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin